Pharmaceuticals, Biotechnology & Life Sciences Companies By Shares Outstanding

Shares Outstanding
Shares OutstandingEfficiencyMarket RiskExp Return
1IDCN Indocan Resources
7.41 B
 0.00 
 0.00 
 0.00 
2PFE Pfizer Inc
5.66 B
 0.02 
 1.58 
 0.02 
3HTDS Hard to Treat
5.48 B
 0.00 
 0.00 
 0.00 
4HLN Haleon plc
4.57 B
 0.03 
 1.43 
 0.04 
5NVO Novo Nordisk AS
4.45 B
 0.07 
 1.92 
 0.14 
6TAK Takeda Pharmaceutical Co
3.14 B
(0.05)
 0.97 
(0.05)
7AZN AstraZeneca PLC ADR
3.1 B
 0.27 
 1.21 
 0.32 
8MRK Merck Company
2.53 B
 0.06 
 1.02 
 0.06 
9SNY Sanofi ADR
2.5 B
 0.08 
 1.30 
 0.11 
10JNJ Johnson Johnson
2.41 B
(0.06)
 1.00 
(0.06)
11NVS Novartis AG ADR
2.04 B
 0.03 
 0.98 
 0.03 
12GSK GlaxoSmithKline PLC ADR
2.04 B
 0.11 
 1.00 
 0.11 
13BMY Bristol Myers Squibb
2.03 B
(0.08)
 1.62 
(0.14)
14SLNX Solanbridge Group
1.96 B
 0.00 
 0.00 
 0.00 
15ABBV AbbVie Inc
1.77 B
(0.07)
 1.26 
(0.09)
16DNA Ginkgo Bioworks Holdings
1.7 B
(0.06)
 5.98 
(0.35)
17EAPH Easton Pharmaceutica
1.34 B
 0.00 
 0.00 
 0.00 
18GILD Gilead Sciences
1.25 B
(0.17)
 0.98 
(0.17)
19VTRS Viatris
1.19 B
 0.03 
 1.67 
 0.05 
20TEVA Teva Pharma Industries
1.13 B
 0.14 
 1.71 
 0.24 
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds. Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.